WEKO3
インデックスリンク
アイテム
Determination of a pain substance produced by the photodegradation of dacarbazine
http://hdl.handle.net/2297/18237
http://hdl.handle.net/2297/182371f3390de-6d4a-477d-9e45-8f4359cec867
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
PH-PR-MIYAMOTO-K-15.pdf (2.1 MB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2017-10-04 | |||||
| タイトル | ||||||
| タイトル | Determination of a pain substance produced by the photodegradation of dacarbazine | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| その他のタイトル | ||||||
| 値 | Dacarbazineの光分解によって生成する発痛物質の探索 | |||||
| 著者 |
Kawahara, Masami
× Kawahara, Masami× Ishida, Tomoyuki× Emoto, Chie× Matsushita, Ryo× Ichimura, Fujio× Kataoka, Osamu× Mukai, Chisato× Hanaoka, Miyoji× Ishizaki, Junko× Miyamoto, Kenichi |
|||||
| 書誌情報 |
臨床薬理 = Japanese journal of clinical pharmacology 巻 32, 号 1, p. 15-22, 発行日 2001-01-01 |
|||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 0388-1601 | |||||
| NCID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AN0025404X | |||||
| DOI | ||||||
| 関連タイプ | isIdenticalTo | |||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | https://doi.org/10.3999/jscpt.32.15 | |||||
| 出版者 | ||||||
| 出版者 | 日本臨床薬理学会 = The Japanese Society of Clinical Pharmacology and Therapeutics | |||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | The anticancer drug, dacarbazine, is known to be photosensitive, and its photodegradation products have been pointed out as the causes of side effects including local venous pain of injection site. In this study, we attempted to clarify the causative substance of pain after photodegradation of dacarbazine. We synthesized five photodegradation products of dacarbazine; dimethylamine, 5-diazoimidazole-4-carboxamide (Diazo-IC), 4-carbamoylimidazolium-5-olate, 4-carbamoyl-2-(4-carbamoylimidazol-5-ylazo) imidazolium-5-olate and 2-azahypoxanthine, and examined pain reactions induced by these substances in mice. Mice were intraperitoneally administered each photodegradation product, then number of stretching reactions or writhing reactions as types of pain behaviors was counted. Only Diazo-IC clearly induced the pain reactions in mice in a concentration-dependent manner: the other products caused no pain reaction. The pain threshold of Diazo-IC in mice was estimated at between 0.1 mg/ml and 0.2 mg/ml. While diclofenac sodium significantly reduced acetic acid-induced pain reactions in mice, it did not influence the reactions induced by Diazo-IC. This result suggests that Diazo-IC-induced pain reactions represent a different mechanism from acetic acid-induced inflammatory pain. Degradation rate constant of 0.1 mg/ml of dacarbazine solution was 10 times larger than 1 mg/ml of dacarbazine. Dacarbazine solution for drip infusion should be sufficiently shielded from light. | |||||
| 権利 | ||||||
| 権利情報 | Copyright (c) 2001 日本臨床薬理学会 | |||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
| 関連URI | ||||||
| 識別子タイプ | URI | |||||
| 関連識別子 | http://www.jscpt.jp/ | |||||
